Highmark, Verizon collaborate on new HIE

Pennsylvania insurer Highmark and telecom giant Verizon are creating a massive new health information exchange, the two companies announced this week.

Once complete, the Highmark HIE will cover much of Pennsylvania and West Virginia, dwarfing the nearest regional exchanges, Heritage Valley Health System and the University of Pittsburgh Medical Center's ClinicalConnect, according to the Pittsburgh Gazette.

The HIE ultimately will be a pay-to-play system. It's meant to be "self-sustaining" and physicians, hospitals and others eventually will have to pay a fee to participate, Highmark officials say. No word yet on what those fees might be, nor how much Highmark and Verizon have spent on the system.

The HIE already has several hospital participants, according to the Pittsburgh Tribune, including the West Penn Allegheny's five-hospital system, Butler Health System, Jefferson Regional Medical Center, MedExpress Urgent Care, Vantage Health Network and The Washington Hospital. 

One potential monkey wrench in the IT project is an ongoing U.S. Department of Justice anti-trust investigation into Highmark's attempted acquisition of the West Penn health system. Highmark is charged with creating a monopoly, price fixing and more. The acquisition deal has not yet closed.  

To learn more:
- read the Pittsburgh Post-Gazette's coverage
- see the Pittsburgh Tribune's story
- look into InsuranceTech.com's article

Report

Driving Engagement in an Evolving Healthcare Ecosystem

Deep-dive into evolving consumer expectations in healthcare today and how leading providers are shaping their infrastructure to connect with patients through virtual care.

Suggested Articles

Telehealth is on the rise. The challenge for providers, however, is to convince patients who may still be skeptical or uncertain.

Starting in 2021, the ONC will launch an initiative called Project [email protected] to create an industrywide healthcare specification for representing addresses.

In turn, UPMC will also become a strategic investor in CarepathRx, officials said.